Romanian  Journal of  Diabetes
Nutrition  and  Metabolic  Diseases

 
 

Instructions for authors

General Data
The Romanian Journal of Diabetes, Nutrition and Metabolic Diseases (RJDNMD) does not accept materials that have been previously published (except for Abstracts) or are considered for publication in other journals. Only papers exclusively sent to RJDNMD will be taken into consideration for publication. Thus, authors are required to submit a statement that their material is original and not previously published or submitted for publication. Authors should acknowledge in the manuscript all financial support and disclose any conflicts of interest that might bias their work. Manuscripts must be written in English. RJDNMD is a Peer Reviewed journal, therefore the articles will be revised both by national and international reviewers.


Types of Published Articles
- Editorials
- Original articles, including fundamental or clinical research
- Reviews (update of theoretical or practical issues from the medical literature)
- Case reports
- Letters to the Editors
- Reports from important professional meetings, book reviews

Organization of Articles - General Structure and Text format requirements
General requirements
- The text of the paper will be written in English, Word format, font 12, spacing - 1,5 lines.
- The article must have a maximum of 12-13 pages

Title, authors and affiliations
- The title of the paper will be written in capital letters and in Bold. For example: EPIDEMIOLOGY OF THE METABOLIC SYNDROME
- The name of the authors will be written in lowercase letters, Bold, Italic, and followed by affiliation in superscript font. For example Alina Popescu1, R?zvan Ionescu2,Cristian Georgescu3 ....
- Authors institution of origin will be written in lowercase letters. For example:
University of Medicine and Pharmacy „Carol Davila”, Bucharest, Romania
Department of Diabetes, Craiova Clinical County Hospital, Craiova, Romania

Abstract The article will be preceded by an abstract of less than 200 words. The abstract will be divided into the follows sections: „Background and Aims”; „Material and Methods”; „Results”; „Conclusions”. The Abstract should not contain unexplained abbreviations.

Key words A maximum of 6 key words will be provided after the Abstract

Original articles organization The original articles should include the following sections: „Background and Aims”; “Material and Methods”; „Results”; „Discussions”; „Conclusions”.
The Background and Aims section should include a clear statement of the aim of the study. It should include no results or conclusions.
The Material and Method section should provide all the information that would allow reproducing the experimental work. Equipment producer, including city and country of origin, must be given. Chemical substances must be properly identified and the supplier must be reported. In case of clinical studies, drugs must be identified by their generic name whenever possible.
Statistical analyses should be detailed in order to allow verifying the reported results. The Software used for statistical analysis should be reported, including the name/acronym and its origin/producer. When variability is expressed in terms of Mean ± SD, the number of observations (n) must also be given. Both sample size and statistical significance should be predefined and p values should be reported.
The Results section should provide the results of the study without discussing them. The same data should not be presented in duplicate in a figure and a table (chose either one as appropriate). Results that are given in tables or figures should not be repeated in extenso in the text. Only the most important observations will be emphasized in the text if previously given in extenso in Tables/Figures. Each Table and Figure will be numbered in Arabic numbers and it is compulsory that they are previously quoted in the text. They will have a title and each one will be accompanied by a legend. Figures can be in color and should be given in high resolution (150 dpi), in a tiff or jpeg format. Figures will be sent both inserted in the text and also as separate files.
The Discussions section should provide an interpretation of the results and not simply reporting again the results. Key points that should be addressed include reporting of: main findings; comparisons with results of similar studies, strengths and weaknesses of the study; unsolved questions/issues; future research that is required.
The Conclusions section should not repeat all the results or the issues addressed in the Discussion section. Only the key findings of the study can be briefly reminded and the main message of the study should be given.

Abbreviations: The abbreviations used will be preceded by the full term at their first use in the text, both in the Abstract and the Article. Only generally recognized abbreviations may be used.

Acknowledgements & Duality of interest Any grant support should be mentioned here as well as the funding agencies that provided financial support. Any editorial assistance should be acknowledged. Authors should also give a disclosure of the conflicts of interest that might represent a bias to the presented data. It should be clearly specified if the paper was sponsored by a company.

References The reference section will comprise a maximum of 50 references. References should be numbered in the order of their insertion in the text. They will be given in square brackets using Arabic numbers. For example [1]; [1,3,4]; [5-8]. References should be numbered in the same order at the end of the manuscript. Only one reference should be given for each number. All references from the list at the end of the manuscript have to be included in the text of the article but not in the Abstract, Results and Conclusions sections. References will be structured using the following format:



Full length papers from journals: Authors’ Last Name followed by initials of the Given Names for the first six authors will be given in Bold font (for ? seven authors, the list should be abbreviated to et al. after the third author’s name); (year); title of paper will be given in full; Name of the Journal will given in its abbreviated form (according to NCBI-NLM catalogue: www.ncbi.nlm.nih.gov/nlmcatalog) in Italic font; Volume Number, Pages of the article, Year of publication. For example: Ferranini E, Natali A, Bell P et al. Insulin resistance and hypertension in obesity. European group for the Study of Insulin Resistance (EGIR). J Clin Invest 100: 1166-1173, 1997.
Abstracts from Journals: The same format as for full length papers should be used but followed by (abstract). For example: Williams-Herman D, Johnson J, Lunceford JK. Initial combination therapy with sitagliptin and metformin provides effective and durable glycemic control over 1 year in patients with Type 2 diabetes (T2DM): a pivotal Phase III clinical trial. Diabetes 56 [Suppl. 1]: 004-LB, 2007. (abstract)
Chapters from Textbooks or Monographs: Authors’ Last Name followed by initials of the Given Names for all authors will be given in Bold font; Chapter Title; In: Title of the book in Italic font; Editors’ names with initials (eds); Publishing House name, city of publishing, pp followed by the first and last page numbers of the quoted material; Publication Year. For example: Hueston JT. Dupuytren diathesis. In: Dupuytren's Disease. McFarlane RM (ed). Churchill Livingstone, Edinburgh, pp 246-249, 1990.

The authors hold full responsibility for quoted texts and reproduced icons.

Correspondence Data The main author will send his/ her full correspondence data: postal address, email, telephone and fax, when submitting.

Submission of Articles The paper will be sent by E-mail to: cristian.guja@b.astral.ro (Cristian Guja). Postal address for submission: National Institute of Diabetes, Nutrition and Metabolic Diseases "Prof. NC Paulescu", 5-7 Ion Movila Street, Bucharest 2, Postal code 020475, Romania.
Each submission will include at least: (1) The article in Microsoft Word format; (2) Each figure as an individual .tiff or .jpg file; (3) The signed statement of the correspondence author that the material is original and not previously published or submitted for publication. The statement should be scanned and sent as a .pdf file.

 
     
 
© 2007 - . All rights reserved. Review of diabetes | Instructions for authors | Articles on diabetes